GLP-1 Neurons in the Nucleus of the Solitary Tract Project Directly to the Ventral Tegmental Area and Nucleus Accumbens to Control for Food Intake

被引:353
作者
Alhadeff, Amber L. [1 ]
Rupprecht, Laura E. [1 ]
Hayes, Matthew R. [1 ]
机构
[1] Univ Penn, Dept Psychiat, Translat Neurosci Program, Sch Med, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
GLUCAGON-LIKE PEPTIDE-1; BODY-WEIGHT; GLUCAGON-LIKE-PEPTIDE-1; RECEPTOR; GASTRIC DISTENSION; GLYCEMIC CONTROL; REWARD; BRAIN; LIRAGLUTIDE; DOPAMINE; RAT;
D O I
10.1210/en.2011-1443
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Central glucagon-like-peptide-1 (GLP-1) receptor activation reduces food intake; however, brain nuclei and mechanism(s) mediating this effect remain poorly understood. Although central nervous system GLP-1 is produced almost exclusively in the nucleus of the solitary tract in the hindbrain, GLP-1 receptors (GLP-1R) are expressed throughout the brain, including nuclei in the mesolimbic reward system (MRS), e. g. the ventral tegmental area (VTA) and the nucleus accumbens (NAc). Here, we examine the MRS as a potential site of action for GLP-1-mediated control of food intake and body weight. Double immunohistochemistry for Fluorogold (monosynaptic retrograde tracer) and GLP-1 neuron immunoreactivity indicated that GLP-1-producing nucleus tractus solitarius neurons project directly to the VTA, the NAc core, and the NAc shell. Pharmacological data showed that GLP-1R activation in the VTA, NAc core, and NAc shell decreased food intake, especially of highly-palatable foods, and body weight. Moreover, blockade of endogenous GLP-1R signaling in the VTA and NAc core resulted in a significant increase in food intake, establishing a physiological relevance for GLP-1 signaling in the MRS. Current data highlight these nuclei within the MRS as novel sites for GLP-1R-mediated control of food intake and body weight. (Endocrinology 153: 647-658, 2012)
引用
收藏
页码:647 / 658
页数:12
相关论文
共 69 条
[2]   Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases [J].
Andrews, Paul L. R. ;
Horn, Charles C. .
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2006, 125 (1-2) :100-115
[3]   Intracerebroventricular glucagon-like peptide-1 (7-36) amide inhibits sham feeding in rats without eliciting satiety [J].
Asarian, L ;
Corp, ES ;
Hrupka, B ;
Geary, N .
PHYSIOLOGY & BEHAVIOR, 1998, 64 (03) :367-372
[4]   Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study [J].
Astrup, Arne ;
Rossner, Stephan ;
Van Gaal, Luc ;
Rissanen, Aila ;
Niskanen, Leo ;
Al Hakim, Mazin ;
Madsen, Jesper ;
Rasmussen, Mads F. ;
Lean, Michael E. J. .
LANCET, 2009, 374 (9701) :1606-1616
[5]   CHOLECYSTOKININ AND BOMBESIN SUPPRESS OPERANT RESPONDING FOR FOOD REWARD [J].
BABCOCK, AM ;
LIVOSKY, M ;
AVERY, DD .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1985, 22 (05) :893-895
[6]   VENTRAL TEGMENTAL AREA OPIOID MECHANISMS AND MODULATION OF INGESTIVE BEHAVIOR [J].
BADIANI, A ;
LEONE, P ;
NOEL, MB ;
STEWART, J .
BRAIN RESEARCH, 1995, 670 (02) :264-276
[7]   Biology of incretins: GLP-1 and GIP [J].
Baggio, Laurie L. ;
Drucker, Daniel J. .
GASTROENTEROLOGY, 2007, 132 (06) :2131-2157
[8]   Hyperphagia and Increased Fat Accumulation in Two Models of Chronic CNS Glucagon-Like Peptide-1 Loss of Function [J].
Barrera, Jason G. ;
Jones, Kenneth R. ;
Herman, James P. ;
D'Alessio, David A. ;
Woods, Stephen C. ;
Seeley, Randy J. .
JOURNAL OF NEUROSCIENCE, 2011, 31 (10) :3904-3913
[9]   The brain, appetite, and obesity [J].
Berthoud, Hans-Rudolf ;
Morrison, Christopher .
ANNUAL REVIEW OF PSYCHOLOGY, 2008, 59 :55-92
[10]   Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes [J].
Blonde, L. ;
Klein, E. J. ;
Han, J. ;
Zhang, B. ;
Mac, S. M. ;
Poon, T. H. ;
Taylor, K. L. ;
Trautmann, M. E. ;
Kim, D. D. ;
Kendall, D. M. .
DIABETES OBESITY & METABOLISM, 2006, 8 (04) :436-447